Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 379Triple Negative Breast Neoplasms 61Ovarian Neoplasms 46Prostatic Neoplasms 35Colorectal Neoplasms 35Neoplasms 28Carcinoma, Non-Small-Cell Lung 27Endometrial Neoplasms 24Lung Neoplasms 22Neoplasm Metastasis 21Uterine Cervical Neoplasms 19Melanoma 18Stomach Neoplasms 17Pancreatic Neoplasms 16Squamous Cell Carcinoma of Head and Neck 15Carcinoma, Renal Cell 14Urinary Bladder Neoplasms 13Sarcoma 12Head and Neck Neoplasms 12Esophageal Neoplasms 11Colonic Neoplasms 10Advanced Breast Cancer 9Small Cell Lung Carcinoma 8Carcinoma, Transitional Cell 8Anatomic Stage I Breast Cancer AJCC v8 8Liver Neoplasms 7Kidney Neoplasms 7Cholangiocarcinoma 7Carcinoma, Hepatocellular 6Brain Neoplasms 6

Interventions

Neoadjuvant Therapy 1Mastectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Cancer Invasive × Breast × 30 days × Clear all
NCT03627988 2026-05-22

MARTA

Institut Claudius Regaud

Phase 2 Completed
66 enrolled
Breast

Breast Cancer Invasive

NCT07590570 2026-05-15

The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer

RenJi Hospital

Active not recruiting
188 enrolled
Breast

Breast Cancer Invasive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡